Clinical trial using ddPCR validates the use of cell-free DNA as a predictive diagnostic tool.
The QX200 PCR System receives CE IVD marking, the first step in extending ddPCR technology to the clinic.
Study identifies novel blood-based biomarker using ddPCR.
One hospital now offers a liquid biopsy test using ddPCR to patients with non‑small cell lung cancer.
Read about challenges and success stories of bringing liquid biopsy to the clinic.